Buy Medpace Holdings | NASDAQ MEDP | Naranj Capital

 BUY   Medpace Holdings (NASDAQ: Medpace Holdings)

Medpace Holdings (NASDAQ: Medpace Holdings) STOCK RECOMMENDATION

Idea BUY
Buy Range 395 – 400
Target 435 – 440
StopLoss* below 360
Duration 15-16 Trading Days
Potential Returns 9 – 10%
Idea Buy Range Target StopLoss* Duration Potential Returns
BUY 395 – 400 435 – 440 below 360 15-16 Trading Days 9 – 10%

* Once the first target hit, reset the StopLoss at your buying price.

Our recommendations are authentic and transparent. Find this recommendation posted in Tradingview and Social Media. Be assured such records are permanent and irreversible.

Medpace Holdings (NASDAQ: Medpace Holdings) STOCK OVERVIEW

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Stock Data
NASDAQ Symbol Medpace Holdings
Sectoral Index Healthcare – Biotechnology
52 Weeks High 419.42
52 Weeks Low 187.03

Medpace Holdings (NASDAQ: Medpace Holdings) - RELATIVE STRENGTH

MEDP-RELATIVE STRENGTH

Relative Performance - Last 1 Year

Medpace Holdings —     NASDAQ —

Medpace Holdings (NASDAQ: Medpace Holdings) - DAILY TECHNICAL ANALYSIS

MEDP-DAILY TECHNICAL ANALYSIS
Medpace Holdings (NASDAQ: Medpace Holdings) - Technical Analysis (Daily)
  • The price is in a strong uptrend.
  • Previously the price was moving upwards through a parallel channel.
  • After the breakout, price has made a correction and took support at near 227 level.
  • After that the price started moving upside and formed a Rounding Bottom pattern to indicate that uptrend will continue.
  • After the breakout, price has made an All Time High at near 420 level.
  • After a short consolidation phase, price again started moving upside.

Medpace Holdings (NASDAQ: Medpace Holdings) - EMA Cross

MEDP-EMA CROSS
Medpace Holdings (NASDAQ: Medpace Holdings) - EMA Cross
  • The short length exponential moving average (10 EMA) is about to cross the long length exponential moving average (20 EMA) from the below, generates bullish signal. Last day’s candle has closed above all these moving averages. This suggests buyers are taking interest in this stock.

Medpace Holdings (NASDAQ: Medpace Holdings) - ADX & DI

Medpace Holdings (NASDAQ: Medpace Holdings) - ADX & DI
  • Increasing ADX value above 20, indicated the strength of the trend, thereby uptrending ADX confirms the bullish or bearish supportive decisions. Along with the rising ADX, and the +DI is above (or crossing) -DI, indicates the long trades should be favoured.

CONCLUSION - Medpace Holdings (NASDAQ: Medpace Holdings) STOCK PRICE FORECAST

Based on our stock trading advice in USA, Medpace Holdings stock price target will be USD 435 – USD 440 in the next 15-16 trading sessions.

Medpace Holdings (NASDAQ: Medpace Holdings) TRADINGVIEW POSITION UPDATE

Follow Medpace Holdings (NASDAQ: Medpace Holdings) TRADING ADVICE On Social Media

MONEY MANAGEMENT AND TRADING RULES

1)  It’s advisable to enter/exit in the recommended range.
2)  Strictly follow the StopLoss as mentioned. Honour it.
3)  Use trailing StopLoss to retain profits.
4)  Diversify trading capital into our other trading recommendations.
5)  Risk only the money what you can afford to lose. Hedge accordingly.

Advisor / ANALYST SUMMARY

The stock trading advice is prepared by the Naranj Capital team under the guidance of Arijit Banerjee, CMT, CFTe. Arijit is a veteran trader and an active investor having in-depth knowledge of financial market research, advanced technical analysis, market cycle, algorithmic trading, and portfolio management. He is a Chartered Market Technician (CMT) accredited by CMT Association USA, the global authority of Technical Analysis and also has been honored as a Certified Financial Technician (CFTe) by the International Federation of Technical Analysts, USA.

Disclosure

The views expressed herein are based solely on information available publicly/internal data/other sources believed to be reliable, but is not necessarily all-inclusive and is not guaranteed as to accuracy. The recommendations provided herein is solely for informational purposes and are not intended to be and must not be taken alone as the basis for an investment/trading decision. Trading and investing are subject to market risk and the securities discussed and opinions expressed herein may not be suitable for all investors. To read the full disclosure, please click here.

Enjoy this recommendation?
Share with your friends

Your return could be more

PROFITABLE!

access our premium recommendations

🇺🇸  A1 Trading Advice

USA Stock Markets NYSE & NASDAQ

Navigate the market like a pro with expert trading signals at your fingertips. Unlock valuable insights and stay ahead of the game.

Pricing

Pricing (in USD)

Email Newsletter

Get Free Saudi Stock Trading Advice

We respect your privacy.

For Any Queries, Call or Whatsapp +91-8335058282

You cannot copy content of this page